Get notified when AGL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Securities Litigation (worsened) — New class action and derivative suits were filed, and the consolidated securities matter advanced to class certification briefing.
agilon swings to $18.0M profit on 7.2% revenue growth, but litigation expands
Filed August 5, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 4, 2025 · ~1 min read
Key Changes
-
high
Net income of $18.0M vs a $104M loss a year ago, driven by medical margin swinging from -$53M to +$197M.
MD&A verify on EDGAR → -
high
Securities litigation expanded: new class action and derivative suit filed, and the consolidated case advanced to class certification.
Legal Proceedings verify on EDGAR → -
high
Credit facility amended twice in 2026, extending maturity to 2028 but adding a $50M minimum cash covenant and reducing revolving commitments.
Notes view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ESTC 10-Q) is open in full — no account needed.
Partner
Trade AGL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify